Protective efficiency of DNA vaccination in Asian seabass (Lates calcarifer) against Vibrio anguillarum

Rucker, 1953, Infectious diseases of Pacific Salmon, Trans Am Fisheries Soc, 83, 307 Austin, 1999 Wong, 1989, A comparative study of Vibrio infections in healthy and diseases marine finfishes cultured in floating cages near Penang, Malaysia, Asian Fish Sci, 3, 353 Anderson, 1991, Diseases of barramundi in aquaculture, Aust Aquacult, 5, 21 Subhasinghe, 1992, Multiple bacteriosis, with special reference to spoilage bacterium Shewanell putrefaciens, in cage culture barramundi in Malaysia, J Aquat Anim Health, 4, 309, 10.1577/1548-8667(1992)004<0309:MBWSRT>2.3.CO;2 Soltani, 1996, The relative susceptibility of fish to infections by Flexibacter columnaris maritimus, Aquaculture, 140, 259, 10.1016/0044-8486(95)01157-9 Azad, 2004, Virulence and histopathology of Vibrio anguillarum like (VAL) bacterium isolated from hatchery produced juveniles of Lates calcarifer (Bloch), Asian Fish Sci, 17, 101 Toranzo, 1990, A review of the taxonomy and seroepizootiology of Vibrio anguillarum, with special reference to aquaculture in the Northwest of Spain, Dis Aquat Org, 9, 73, 10.3354/dao009073 Joosten, 1997, Oral vaccination of fish against Vibrio anguillarum using alginate microparticles, Fish Shellfish Immunol, 7, 471, 10.1006/fsim.1997.0100 Coeurdacier, 1997, Alterations in total protein, IgM and specific antibody activity of male and female sea bass (Dicentrarchus labrax L., 1758) sera following injection with killed Vibrio anguillarum, Fish Shellfish Immunol, 7, 151, 10.1006/fsim.1996.0071 Boesen, 1997, Immune response of Rainbow trout (Oncorhynchus mykiss) to antigenic preparations from Vibrio anguillarum serogroup O1, Fish Shellfish Immunol, 7, 543, 10.1006/fsim.1997.0105 Heppell, 2000, Application of DNA vaccine technology to aquaculture, Adv Drug Deliv Rev, 43, 29, 10.1016/S0169-409X(00)00075-2 Kwang, 2000, Fishing for vaccines, Nat Biotechnol, 18, 1145, 10.1038/81122 Wang, 2003, Role for the major outer membrane protein from Vibrio anguillarum in bile resistance and biofilm formation, Microbiology, 149, 1061, 10.1099/mic.0.26032-0 Horne, 1983, The adhesion of Vibrio anguillarum to host tissues and its role in pathogenesis, J Fish Dis, 6, 461, 10.1111/j.1365-2761.1983.tb00100.x Olsson, 1996, Is turbot, Scophthalmus maximus (L.), intestine a portal of entry for the fish pathogen Vibrio anguillarum, J Fish Dis, 19, 225, 10.1111/j.1365-2761.1996.tb00129.x Olsson, 1998, Survival, persistence, and proliferation of Vibrio anguillarum in juvenile turbot, Scophthalmus maximus (L.), intestine and faeces, J Fish Dis, 21, 1, 10.1046/j.1365-2761.1998.00327.x Costerton, 1987, Bacterial biofilms in nature and Diseases, Annu Rev Microbiol, 41, 435, 10.1146/annurev.mi.41.100187.002251 Costerton, 1995, Microbial biofilms, Annu Rev Microbiol, 49, 711, 10.1146/annurev.mi.49.100195.003431 Simón, 1996, Characterization of a porin from the outer membrane of Vibrio anguillarum, J Bacteriol, 178, 4182, 10.1128/jb.178.14.4182-4188.1996 1998, Evaluation of the immunospecificity of the porin om1 of Vibrio anguillarum serotype 01, J Appl Microbiol, 84, 709, 10.1046/j.1365-2672.1998.00398.x Lorenzen, 1998, Protective immunity of VHS in rainbow trout (Oncorhynchus mykiss, Walbaum) following DNA vaccination, Fish Shellfish Immunol, 8, 261, 10.1006/fsim.1997.0134 Corbeil, 1999, Evaluation of the protective immunogenicity of the N, P, M, NV and G proteins of infectious hematopoietic necrosis virus in rainbow trout Oncorhynchus mykiss using DNA vaccines, Dis Aquat Org, 39, 29, 10.3354/dao039029 Vazquez-Juarez, 2005, Evaluation of DNA vaccination of spotted sand bass (Paralabrax maculatofasciatus) with two major outer-membrane protein-encoding genes from Aeromonas veronii, Fish Shellfish Immunol, 19, 153, 10.1016/j.fsi.2004.12.007 Amend, 1981, Potency testing of fish vaccines, 447 Jung, 2005, Immunization with major outer membrane protein of Vibrio vulnificus elicits protective antibodies in a murine model, J Microbiol, 43, 437 Andre, 1998, Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage, J Virol, 72, 1497, 10.1128/JVI.72.2.1497-1503.1998 Uchijima, 1998, Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium, J Immunol, 161, 5594 Nagata, 1999, Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms, Biochem Biophys Res Commun, 261, 445, 10.1006/bbrc.1999.1050 Zur Megede, 2000, Increased expression and immunogenicity of sequence-modified human immuno deficiency virus type 1 gag gene, J Virol, 74, 2628, 10.1128/JVI.74.6.2628-2635.2000 Stratford, 2000, Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus, Vaccine, 19, 810, 10.1016/S0264-410X(00)00246-2 Narum, 2001, Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice, Infect Immun, 69, 7250, 10.1128/IAI.69.12.7250-7253.2001 Cid-Arregui, 2003, A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies, J Virol, 77, 4928, 10.1128/JVI.77.8.4928-4937.2003 Penttila, 2001, Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2), Vaccine, 19, 1256, 10.1016/S0264-410X(00)00237-1 Zhang, 1999, Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain, Immunology, 96, 314, 10.1046/j.1365-2567.1999.00682.x Smooker, 1999, Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression, Parasite Immunol, 21, 357, 10.1046/j.1365-3024.1999.00235.x Svanholm, 1999, Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion, J Immunol Methods, 228, 121, 10.1016/S0022-1759(99)00086-1 Price, 2001, Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa, Infect Immun, 69, 3510, 10.1128/IAI.69.5.3510-3515.2001 Donnelly, 2000, Antigen presentation and DNA vaccines, American J Respir Crit Care Med, 162, S190, 10.1164/ajrccm.162.supplement_3.15tac10 Deliyannis, 2000, A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge, Proc Natl Acad Sci USA, 97, 6676, 10.1073/pnas.120162497 Fredriksen, 2006, DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells, Mol Ther, 13, 776, 10.1016/j.ymthe.2005.10.019 Meng, 2003, CpG oligodeoxynucleotides activate grass carp (Ctenopharyngodon idellus) macrophages, Dev Comp Immunol, 27, 313, 10.1016/S0145-305X(02)00104-0 Ioannou, 2002, CpG containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpes virus glycoprotein, Vaccine, 21, 127, 10.1016/S0264-410X(02)00378-X Ioannou, 2002, The immunogenicity and protective efficacy of bovine herpes virus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligo-deoxynucleotides, J Virol, 76, 9002, 10.1128/JVI.76.18.9002-9010.2002 Davis, 1998, CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen, J. Immunol, 160, 870 Klinman, 1999, CpG motifs as immune adjuvants, Vaccine, 17, 19, 10.1016/S0264-410X(98)00151-0 Chu, 1997, CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity, J Exp Med, 186, 1623, 10.1084/jem.186.10.1623 Zhang, 1997, DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection, J Infect Dis, 176, 1035, 10.1086/516545 Lutwyche, 1995, A conserved Aeromonas salmonicida porin provides protective immunity to rainbow trout, Infect Immun, 63, 3137, 10.1128/IAI.63.8.3137-3142.1995 Yin, 1996, The role of specific antiserum of catfish, Clarias gariepinus, as a defence against Aeromonas hydrophila, Fish Shellfish Immunol, 6, 57, 10.1006/fsim.1996.0006 Chandran, 2002, Immunisation of Indian major carps against Aeromonas hydrophila by intraperitoneal injection, Fish Shellfish Immunol, 13, 1, 10.1006/fsim.2001.0374 Bricknell, 1999, Duration of protective antibodies, and the correlation with protection in Atlantic salmon (Salmo salar L.) following vaccination with an Aeromonas salmonicida vaccine containing iron-regulated outer membrane proteins and secretory polysaccharide, Fish Shellfish Immunol, 9, 139, 10.1006/fsim.1998.0183 Boesen, 1999, Bactericidal activity by sub-agglutinating levels of rainbow trout (Oncorhynchus mykiss) antiserum to Vibrio anguillarum serogroup O1, Fish Shellfish Immunol, 9, 633, 10.1006/fsim.1999.0216